- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2024 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
The Tisch Cancer Institute at Mount Sinai | Strategic Alliance Partners
Latest from The Tisch Cancer Institute at Mount Sinai
Novel Triplet Combos Offer Deep Remissions in Relapsed/Refractory Multiple Myeloma
September 16, 2020
Article
Joshua Richter, MD, discusses the importance of optimizing these novel therapies to make way for precision medicine in multiple myeloma.
Dr. Mascarenhas on the Potential Role of Pacritinib in MPNs
September 10, 2020
Video
John O. Mascarenhas, MD, discusses the potential role of pacritinib in myeloproliferative neoplasms.
Dr. Richard on the Benefit of Adding Daratumumab to Standard-of-Care Rd in Myeloma
September 08, 2020
Video
Shambavi Richard, MD, discusses the benefit of adding daratumumab to lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma.
Dr. Chari on the FDA Approval of Belantamab Mafodotin in R/R Multiple Myeloma
September 08, 2020
Video
Ajai Chari, MD, discusses the approval of belantamab mafodotin-blmf in relapsed/refractory multiple myeloma.
Dr. Richter on the Importance of Optimizing Available Therapies in Multiple Myeloma
September 02, 2020
Video
Joshua Richter, MD, discusses the importance of optimizing available therapies in multiple myeloma.
Dr. Richard on the Evolving Armamentarium in Multiple Myeloma
September 01, 2020
Video
Shambavi Richard, MD, highlights the rapidly evolving armamentarium in multiple myeloma.
Dr. Richter on the Utility of Isatuximab in Relapsed/Refractory Myeloma
August 31, 2020
Video
Joshua Richter, MD, discusses the utility of isatuximab in relapsed/refractory multiple myeloma.
Novel Therapies Move Through the Relapsed/Refractory Myeloma Pipeline
August 28, 2020
Article
Ajai Chari, MD, discusses the recent approval of belantamab mafodotin in relapsed/refractory multiple myeloma and other emerging agents under exploration in the space.
Dr. Hormigo on the Current Treatment Landscape of Glioblastoma
August 26, 2020
Video
Adilia Hormigo, MD, PhD, discusses the current treatment landscape of glioblastoma.
Dr. Chari on Investigational Belantamab Mafodotin Combos in Myeloma
August 20, 2020
Video
Ajai Chari, MD, discusses next steps with belantamab mafodotin-blmf and combination studies in multiple myeloma.
Dr. Richard on Treatment According to Transplant Eligibility in Multiple Myeloma
August 20, 2020
Video
Shambavi Richard, MD, discusses treatment according to transplant eligibility in multiple myeloma.
Dr. Hoffman on the Current Polycythemia Vera Treatment Paradigm
June 05, 2020
Video
Ronald Hoffman, MD, discusses the current polycythemia vera treatment paradigm.
Dr. Sfakianos on the Utility of Adjuvant Therapy in Bladder Cancer Management
June 03, 2020
Video
John P. Sfakianos, MD, discusses the utility of adjuvant therapy in bladder cancer management.
Dr. Brody on Addressing Acquired Resistance to Immunotherapy in Non-Hodgkin Lymphoma
May 28, 2020
Video
Joshua Brody, MD, discusses addressing required resistance to immunotherapy in non-Hodgkin lymphoma.
Ruxolitinib Discontinuation in Myelofibrosis Leads to Increased Morbidity Burden, Underscoring Unmet Need
May 18, 2020
Article
John O. Mascarenhas, MD, discusses patient characteristics and outcomes following ruxolitinib discontinuation in myelofibrosis and research efforts being made to address a large unmet need in the space.
Dr. Tsao on Improving Outcomes in RCC
May 16, 2020
Video
Che-Kai Tsao, MD, shares strategies to improve outcomes in renal cell carcinoma.
Dr. Tsao on Improving Outcomes in RCC
May 15, 2020
Video
Che-Kai Tsao, MD, shares strategies to improve outcomes in renal cell carcinoma.
Dr. Sfakianos on Importance of Restaging Transurethral Resection of Bladder Tumors
May 13, 2020
Video
John P. Sfakianos, MD, discusses the importance of restaging transurethral resection of bladder tumors.
Dr. Sfakianos on Importance of Restaging Transurethral Resection of Bladder Tumors
May 12, 2020
Video
John P. Sfakianos, MD, discusses the importance of restaging transurethral resection of bladder tumors.
Dr. Oh on Challenges With Developing Novel Targeted Agents in Prostate Cancer
May 05, 2020
Video
William K. Oh, MD, discusses challenges with developing novel targeted agents in prostate cancer.